159 related articles for article (PubMed ID: 8634526)
1. Pharmacological characterization of Sephadex-induced oedema in rat paws: predominant role of serotonin and platelet-activating factor.
Francischi JN; Dias MF; Rocha OA; de Abreu Castro MS; Kiyomi Funayama Tatsuo MA; Farinelli P; Pacheco CM; Ferreira-Alves DL; Sirois P
Int Arch Allergy Immunol; 1996 Apr; 109(4):398-406. PubMed ID: 8634526
[TBL] [Abstract][Full Text] [Related]
2. Platelet activating factor potentiates rat paw oedema induced by different phlogogen agents.
Izzo AA; Mascolo N; Di Urno MV; Autore G; Di Carlo G; Capasso F
Agents Actions; 1994 May; 41(3-4):140-3. PubMed ID: 7524288
[TBL] [Abstract][Full Text] [Related]
3. Involvement of B1 and B2 receptors in bradykinin-induced rat paw oedema.
Campos MM; Calixto JB
Br J Pharmacol; 1995 Mar; 114(5):1005-13. PubMed ID: 7780633
[TBL] [Abstract][Full Text] [Related]
4. Mediation by bradykinin of rat paw oedema induced by collagenase from Clostridium histolyticum.
Legat FJ; Griesbacher T; Lembeck F
Br J Pharmacol; 1994 Jun; 112(2):453-60. PubMed ID: 7915609
[TBL] [Abstract][Full Text] [Related]
5. Enterolobin induces rat paw oedema independently of PAF-acether.
Castro-Faria-Neto HC; Cordeiro RS; Martins MA; Correia-Da-Silva AC; Bozza PT; Sousa MV; Morhy L
Mem Inst Oswaldo Cruz; 1991; 86 Suppl 2():129-31. PubMed ID: 1841984
[TBL] [Abstract][Full Text] [Related]
6. Inhibition by rapamycin of leukocyte migration and bronchial hyperreactivity induced by injection of Sephadex beads to guinea-pigs.
Nogueira de Francischi J; Conroy DM; Maghni K; Sirois P
Br J Pharmacol; 1993 Dec; 110(4):1381-6. PubMed ID: 7508325
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological modulation of 2-methyl-carbamate-PAF induced rat paw oedema.
Castro-Faria-Neto HC; Silva PM; Martins MA; Silva PS; Henriques MG; Cordeiro RS; Vargaftig BB
J Pharm Pharmacol; 1990 Mar; 42(3):203-4. PubMed ID: 1974620
[TBL] [Abstract][Full Text] [Related]
8. The mediators involved in endotoxin-induced vascular permeability increase in the rat skin and their interactions.
Ueno A; Tokumasu T; Naraba H; Oh-ishi S
Jpn J Pharmacol; 1996 Apr; 70(4):285-90. PubMed ID: 8774757
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological evaluation of rat paw oedema induced by Bothrops jararaca venom.
Trebien HA; Calixto JB
Agents Actions; 1989 Mar; 26(3-4):292-300. PubMed ID: 2660497
[TBL] [Abstract][Full Text] [Related]
10. Drug modulation of antigen-induced paw oedema in guinea-pigs: effects of lipopolysaccharide, tumour necrosis factor and leucocyte depletion.
da Motta JI; Cunha FQ; Vargaftig BB; Ferreira SH
Br J Pharmacol; 1994 May; 112(1):111-6. PubMed ID: 8032630
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological and histopathological characterization of Bothrops lanceolatus (Fer de lance) venom-induced edema.
Guimarães AQ; Cruz-Höfling MA; Ferreira de Araújo PM; Bon C; Lôbo de Araújo A
Inflamm Res; 2004 Jul; 53(7):284-91. PubMed ID: 15241562
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of mouse hind paw oedema induced by Bothrops insularis (jararaca ilhoa) snake venom.
Barbosa AM; do Amaral RO; Teixeira CF; Hyslop S; Cogo JC
Toxicon; 2003 Oct; 42(5):515-23. PubMed ID: 14529733
[TBL] [Abstract][Full Text] [Related]
13. Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents.
Merlos M; Gómez LA; Vericat L; García-Rafanell J; Forn J
Pharmacology; 1990; 40(4):211-7. PubMed ID: 1697076
[TBL] [Abstract][Full Text] [Related]
14. The role of B1 and B2 kinin receptors in oedema formation after long-term treatment with Mycobacterium bovis bacillus Calmette-Guérin (BCG).
Campos MM; Henriques MG; Calixto JB
Br J Pharmacol; 1997 Feb; 120(3):502-8. PubMed ID: 9031756
[TBL] [Abstract][Full Text] [Related]
15. C-reactive protein specifically enhances platelet-activating factor-induced inflammatory activity in vivo.
Sato A; Oe K; Yamanaka H; Yokoyama I; Ebina K
Eur J Pharmacol; 2014 Dec; 745():46-51. PubMed ID: 25455842
[TBL] [Abstract][Full Text] [Related]
16. Mediators of the inflammation induced in the rat paw by carrageenin.
Crunkhorn P; Meacock SC
Br J Pharmacol; 1971 Jul; 42(3):392-402. PubMed ID: 4104654
[TBL] [Abstract][Full Text] [Related]
17. Mast cell involvement in the rat paw oedema response to 1,8-cineole, the main constituent of eucalyptus and rosemary oils.
Santos FA; Rao VS
Eur J Pharmacol; 1997 Jul; 331(2-3):253-8. PubMed ID: 9274987
[TBL] [Abstract][Full Text] [Related]
18. The pharmacological profile of ovalbumin-induced paw oedema in rats.
Feitosa RF; Melcíades GB; Assreuy AM; Rocha MF; Ribeiro RA; Lima AA
Mediators Inflamm; 2002 Jun; 11(3):155-63. PubMed ID: 12137244
[TBL] [Abstract][Full Text] [Related]
19. Desensitization to PAF-induced rat paw oedema by repeated intraplantar injections.
Cordeiro RS; Martins MA; Silva PM; Faria Neto HC; Castanheira JR; Vargaftig BB
Life Sci; 1986 Nov; 39(20):1871-8. PubMed ID: 3773645
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of carrageenin-induced rat paw oedema by crotapotin, a polypeptide complexed with phospholipase A2.
Landucci EC; Antunes E; Donato JL; Faro R; Hyslop S; Marangoni S; Oliveira B; Cirino G; de Nucci G
Br J Pharmacol; 1995 Feb; 114(3):578-83. PubMed ID: 7537590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
